MedTrace Logo

Antihemostatic Therapy and Endoscopic Biliary Sphincterotomy Induced Bleeding

NCT01098617 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2010-04-05

No results posted yet for this study

Summary

The aim of the study is to observe the effects of antihemostatic therapy including nonsteroidal antiinflammatory, anticoagulant and antiaggregant therapy and other patient and procedure related factors on the risk of endoscopic biliary sphincterotomy induced bleeding.

Conditions

  • Endoscopic Biliary Sphincterotomy
  • Bleeding

Sponsors & Collaborators

  • Yuksek Ihtisas Hospital

    lead OTHER

Principal Investigators

  • Meral Akdoğan, MD · Turkiye Yuksek Ihtisas Hospital Gastroenterology Department

  • Ibrahim Koral Onal, MD · Turkiye Yuksek Ihtisas Hospital Gastroenterology Department

  • Erkan Parlak, MD · Turkiye Yuksek Ihtisas Hospital Gastroenterology Department

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-11-30
Completion
2010-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01098617 on ClinicalTrials.gov